Chapter 13 Modified Nucleosides and Nucleobases in Urine and Serum as Selective Markers for The Whole-Body Turnover of tRNA, rRNA and mRNA-CAP - Future Prospects and Impact
- 1 January 1990
- book chapter
- Published by Elsevier
- p. C389-C441
- https://doi.org/10.1016/s0301-4770(08)61551-1
Abstract
No abstract availableThis publication has 65 references indexed in Scilit:
- Urinary pseudouridine as a tumor marker in patients with small cell lung cancerClinica Chimica Acta; International Journal of Clinical Chemistry, 1986
- Protein and RNA Turnover in Preterm Infants and Adults: A Comparison Based on Urinary Excretion of 3-Methylhistidine and of Modified One-Way RNA CatabolitesAnnals of Nutrition and Metabolism, 1986
- Urinary excretion of modified purines and nucleosides in immunodeficient childrenBiochemical Medicine, 1985
- Modified ribonucleosides as biological markers for patients with small cell carcinoma of the lungEuropean Journal of Cancer and Clinical Oncology, 1982
- Correlation between the abundance of yeast transfer RNAs and the occurrence of the respective codons in protein genesJournal of Molecular Biology, 1982
- tRNA breakdown products as markers for cancerCancer, 1979
- Use of Serum Creatinine Concentrations to Determine Renal Function1Clinical Pharmacokinetics, 1979
- The methylated nucleotide sequences in HeLa cell ribosomal RNA and its precursorsJournal of Molecular Biology, 1974
- Stability of nuclear RNA in mammalian cellsJournal of Molecular Biology, 1974
- Studies on the half life time of rat liver transfer RNA speciesFEBS Letters, 1970